Close menu




Comments

Photo credits: pixabay.com

Commented by Stefan Feulner on July 13th, 2022 | 14:23 CEST

Renewable energies on the verge of a comeback - JinkoSolar, dynaCERT, Nel ASA

  • Hydrogen

Despite the statement of the politicians to build renewable energies even faster and on an even larger scale in the future, the corresponding market leaders correct strongly and reduce the admittedly exaggerated valuations of 2020 and 2021. After losses of sometimes more than 50%, hydrogen wind or photovoltaic stocks are becoming interesting again, at least selectively, to be able to outperform one' s portfolio in the coming years.

Read

Commented by Stefan Feulner on July 12th, 2022 | 14:12 CEST

Erin Ventures with multiplication potential, BYD on top, Nordex looking for the bottom

  • Electromobility
  • boron
  • renewableenergies

The capital markets are going crazy at the moment. Volatilities are rising on the one hand due to uncertainties regarding fears of recession, and on the other hand, due to worries about too large interest rate jumps. The safe-haven gold is losing more and more value every day, and the euro is heading towards parity. Shares in future technologies, the construction of which is expected to be significantly accelerated by Russia's invasion, also continue to be in correction mode. However, opportunities lurk here, especially in the long term, which can significantly outperform the market.

Read

Commented by Nico Popp on July 12th, 2022 | 14:09 CEST

Waiting is not an option! BioNTech, MAS Gold, BASF

  • Gold
  • Biotechnology
  • Inflation

Inflation is rising and rising. In construction, inflation has already reached almost 20%. Even in everyday life, double-digit inflation rates are not far away. At the same time, infection figures are rising, and it is still uncertain whether gas will flow through Nord Stream 1 again in the coming weeks. Given this mixed situation, many investors are asking how they should invest. Because one thing is clear: waiting is not an option - the real return on many asset classes is clearly negative. We take a look at three stocks and check their future prospects.

Read

Commented by Armin Schulz on July 11th, 2022 | 15:35 CEST

BYD, First Hydrogen, Amazon - Electric vehicles on the brink of extinction?

  • Hydrogen
  • fuelcell
  • Electromobility

Alongside industry leader Tesla, Chinese carmakers, in particular, have been early adopters of e-cars. Since the end of the internal combustion engine was decided, there has been a battle for the one emission-free drive. For a long time, electromobility seemed to be winning the race, but charging times are still too long and ranges are limited. These are important factors, especially in the logistics sector. Now the first series production of hydrogen cars is starting in China. Changan Automobile, founded in 1862, claims a range of 700km for its hydrogen cars with a refueling time of a few seconds. Is this the beginning of the end for electric vehicles?

Read

Commented by Stefan Feulner on July 11th, 2022 | 15:33 CEST

Easing at BioNTech and BASF, and Almonty Industries with a clear signal

  • Tungsten
  • Biotechnology

Concerns about the onset of a global recession are increasing dramatically, as shown by the economic data published last week. As a result, almost all asset classes corrected, and the fluctuation range increased enormously. In addition to the stock markets, which have been in a correction for months, crypto and precious metals prices also fell sharply. Even the oil price, which has been booming due to the Russian sanctions, was dragged down. At current levels, however, attractive, anti-cyclical entry opportunities are emerging.

Read

Commented by André Will-Laudien on July 11th, 2022 | 15:32 CEST

Take advantage of the crash in these stocks: Infineon, Siemens, BrainChip and Apple in focus!

  • chips
  • Technology
  • Investments

High-tech, cars, household appliances, smartphones, renewables - the list of products seems endless. What they all have in common is the need for smart chips: But the effects of the global chip shortage are omnipresent. From today's perspective, leaders would undoubtedly like to turn globalization back a bit because the relocation of production sites around the world is creating huge problems ranging from logistics to high procurement prices to completely destroyed supply chains. If Central Europe does not grasp its energy dependence on the East soon, hard times may lie ahead for local industrial locations. Where are the opportunities in a fragile environment?

Read

Commented by Nico Popp on July 11th, 2022 | 15:29 CEST

What if everything turns out well? Nordex, Aspermont, Deutsche Bank

  • Investments

The R-word is currently doing the rounds - and is playing a major role in ensuring that the downward economic spiral accelerates even faster. Yet the US economy is still doing well. Although economic data always refers to the past, the purchasing managers' index and labor market data speak a clear language. A recession looks different. But why is the stock market sky still not full of violins after last week's correction? We take three stocks as examples and do the comeback check for the stock market.

Read

Commented by Juliane Zielonka on July 8th, 2022 | 20:19 CEST

BASF, Amazon, Barsele Minerals - Crisis-proof investments

  • Gold
  • PreciousMetals
  • ecommerce

Some treasures in Europe and neighboring countries offer real pearls of return for investors. A look at the Scandinavian north is worth its weight in gold and can bring calm to the portfolio. BASF has also earned some calm - the chemical giant warns of a bumpy second half and is actively reshaping its energy supply. While tech stocks continue to lose ground, Amazon can rejoice: with Prime Day coming soon, 200 million subscribers in 21 countries will be encouraged to buy bargains. What is worthwhile now as an investment for which risk awareness?

Read

Commented by Fabian Lorenz on July 7th, 2022 | 14:33 CEST

A big surprise at BioNTech, and what are Valneva and NervGen doing?

  • Biotechnology
  • research

Surprise at BioNTech: competitor CureVac sues the Mainz-based biotech company for alleged patent infringements. Specifically, the lawsuit concerns BioNTech's Corona vaccine, which is based on mRNA technology. CureVac founder Ingmar Hoerr, in turn, is considered the discoverer of this new vaccination technology. However, CureVac failed with the development of its own Corona vaccine. Valneva also had no luck with its Corona vaccine, but it seems to have an attractive product pipeline. Nevertheless, the euphoria over the entry of the US pharmaceutical group Pfizer has faded. The situation at NervGen is different: according to experts, NervGen could achieve its greatest success in decades with NVG-291 in the fight against Alzheimer's disease. Tomorrow, a capital increase is to be completed, and the share price will likely regain momentum.

Read

Commented by Juliane Zielonka on July 7th, 2022 | 14:27 CEST

Asset mix: Allianz, Nordex, Globex Mining - What belongs in the portfolio now?

  • PreciousMetals
  • insurance
  • GreenTech

In economically volatile times, a smart investment strategy with possible shifts in the portfolio is needed. Which asset mix brings the strongest returns for investors? And what should be paid attention to, especially concerning renewable energies and wind power? Besides classic gold as a safe investment, there is the possibility of a minerals bank offering a diversified range of products. And is a top dog like Allianz still worth investing in?

Read